{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1.8","upperLimit":"6.9","value":"3.8"}]}]}],"denomUnitsSelected":"courses","denoms":[{"counts":[{"groupId":"OG000","value":"76"}],"units":"Participants"},{"counts":[{"groupId":"OG000","value":"263"}],"units":"courses"}],"description":"For the subset of patients with metastatic disease (high-risk group patients), during induction, the proportion percentage of courses during which subsequent chemotherapy administration was delayed for more than 7 days due to toxicity will be calculated. Patients were to receive 4 courses of induction and then consolidation chemotherapy.","dispersionType":"95% Confidence Interval","groups":[{"description":"Patients with central nervous system (CNS) metastatic disease","id":"OG000","title":"High-Risk Group"}],"paramType":"NUMBER","populationDescription":"Eligible high-risk group patients who started therapy were included in this analysis (n=76). 1 patient enrolled on the high-risk arm did not start therapy due to early disease progression and was excluded. Courses 2-4 of induction and the 1st consolidation course were used in this analysis. 76 patients (with 263 courses) were included.","reportingStatus":"POSTED","timeFrame":"From on-study date up to 4 months after on-study date","title":"Feasibility and Toxicity of Administering Vinblastine With Induction Chemotherapy for Patients With Metastatic Disease as Measured by the Percentage of Courses Delayed for More Than 7 Days Due to Toxicity","type":"SECONDARY","typeUnitsAnalyzed":"courses","unitOfMeasure":"Percentage of courses delayed"}